Global HIV, viral hepatitis epidemics and sexually transmitted infections (STIs) continue to pose significant public health challenges, causing 2.5 million deaths each year, according to a new WHO report – Implementing the global health sector strategies on HIV, viral hepatitis and sexually transmitted infections, 2022–2030.
FDA grants RMAT status for BlueRock’s Parkinson’s therapy
Bemdaneprocel is created to replace the dopamine-producing neurons lost due to Parkinson’s disease. Credit: Annick Vanblaere from Pixabay. The US Food and Drug Administration (FDA)
May 31, 2024